The study of neuroactive substance within senile plaques--with special reference to somatostatin and substance P
Shoji, M.; Harigaya, Y.; Okamoto, K.; Yamaguchi, H.; Hirai, S.
Rinsho Shinkeigaku 28(1): 67-73
1988
ISSN/ISBN: 0009-918X PMID: 2454774 Document Number: 326285
Document emailed within 1 workday
Related Documents
Landheim, A.S.; Bakken, K.; Vaglum, P. 2006: What characterizes substance abusers who commit suicide attempts? Factors related to Axis i disorders and patterns of substance use disorders. a study of treatment-seeking substance abusers in Norway European Addiction Research 12(2): 102-108Kurosumi, K. 1971: Ultrastructure of the rat posterior pituitary gland, with special reference to the release mechanism of the neurosecretory substance Medical Journal of Osaka University 21(2): 53-73
Yoshida, K. 1970: Infection and immunity of Staphylococcus aureus with special reference to the role of capsule and capsular substance in experimental staphylococcal infection Nihon Saikingaku Zasshi. Japanese Journal of Bacteriology 25(7): 335-342
Magnusson, I.; Thulin, L.; Einarsson, K.; Bergström, K. 1984: Effects of substance P and somatostatin on taurocholate-stabilized and CCK- or secretin-induced choleresis in the anesthetized dog Scandinavian Journal of Gastroenterology 19(8): 1007-1014
Browne, F.A.; Wechsberg, W.M. 2010: The intersecting risks of substance use and HIV risk among substance-using South African men and women Current Opinion in Psychiatry 23(3): 205-209
Farmer, R.F.; Kosty, D.B.; Seeley, J.R.; Gau, J.M.; Klein, D.N. 2019: Family Aggregation of Substance use Disorders: Substance Specific, Nonspecific, and Intrafamilial Sources of Risk Journal of Studies on Alcohol and Drugs 80(4): 462-471
Floyd, L.J.; Hedden, S.; Lawson, A.; Salama, C.; Moleko, A.Gloria.; Latimer, W. 2010: The association between poly-substance use, coping, and sex trade among black South African substance users Substance use and Misuse 45(12): 1971-1987
Thor, P.; Laskiewicz, J.; Konturek, J.; Konturek, S.J. 1987: The effects of neuropeptides: substance P, somatostatin, neurotensin and enkephalins on the myoelectric activity of the small intestine Materia Medica Polona. Polish Journal of Medicine and Pharmacy 19(1): 47-51
Whitesell, N.Rumbaugh.; Beals, J.; Mitchell, C.M.; Manson, S.M.; Turner, R.Jay.; Big Crow, C.K.; Buchwald, D.; Chambers, B.; Christensen, M.L.; Dillard, D.A.; DuBray, K.; Espinoza, P.A.; Fleming, C.M.; Wilson Frederick, A.; Gone, J.; Gurley, D.; Jervis, L.L.; Jim, S.M.; Kaufman, C.E.; Klein, S.A.; Lee, D.; Manson, S.M.; McNulty, M.C.; Middlebrook, D.L.; Moore, L.A.; Nez, T.D.; Norton, I.M.; Novins, D.K.; O'Nell, T.; Orton, H.D.; Randall, C.J.; Sam, A.; Shore, J.H.; Simpson, S.G.; Yazzie, L. 2009: Childhood exposure to adversity and risk of substance-use disorder in two American Indian populations: the meditational role of early substance-use initiation Journal of studies on alcohol and drugs 70(6): 971-981
Wang, X.Y.; Wong, W.C.; Ling, E.A. 1995: Ultrastructural localisation of substance P, vasoactive intestinal peptide and somatostatin immunoreactivities in the submucous plexus of guinea pig ileum Journal of Anatomy 186: 187-196
Lolova, I.; Davidoff, M.; Itzev, D.; Apostolov, A.; Ivanchev, I. 1986: Distribution of substance P-, methionine-enkephalin-, somatostatin- and serotonin-immunoreactive nerve elements of the large bowel in Hirschsprung's disease Zentralblatt für Allgemeine Pathologie U. Pathologische Anatomie 132(1): 25-32
Fisun, A.I.; Kuvshinov, K.É; Shamreĭ, V.K.; Alekseev, V.V.; Goncharenko, A.I.; Pastushenkov, A.V.; Tikhenko, V.V. 2014: Prophylaxis of substance abuse in the Armed Forces: organization and performance of screening. Problem of substance dependence disorders is the actual for many countries in the world and affects on health of servicemen Voenno-Meditsinskii Zhurnal 335(3): 4-12
Pedersen, J.M. 1994: Substance abuse among school children in Greenland in 1992. a nation-wide follow-up study of substance abuse habits among school children Ugeskrift for Laeger 156(27): 4036-4038
1999: Center for Mental Health Services; Center for Substance Abuse Treatment; fiscal year 1999 funding opportunity. Department of Health and Human Services, Substance Abuse and Mental Health Services Administration, Center for Mental Health Services (CMHS), Center for Substance Abuse Treatment (CSAT). Notice of availability of funds for cooperative agreements for CMHS/CSAT collaborative program on homeless families: women with psychiatric, substance u Federal register 64(108): 30350-30352
Velázquez, R.A.; Kitto, K.F.; Larson, A.A. 1997: CP-96,345, which inhibits [3H] substance P binding, selectively inhibits the behavioral response to intrathecally administered N-methyl-D-aspartate, but not substance P, in the mouse Journal of Pharmacology and Experimental Therapeutics 281(3): 1231-1237
Okamoto, Y.; Shirotori, K.; Kudo, K.; Ishikawa, K.; Ito, E.; Togawa, K.; Saito, I. 1993: Cytokine expression after the topical administration of substance P to human nasal mucosa. the role of substance P in nasal allergy Journal of Immunology 151(8): 4391-4398
1990: American Academy of Pediatrics Provisional Committee on Substance Abuse: Selection of substance abuse treatment programs Pediatrics 86(1): 139-140
Stanisz, A.M.; Befus, D.; Bienenstock, J. 1986: Differential effects of vasoactive intestinal peptide, substance P, and somatostatin on immunoglobulin synthesis and proliferations by lymphocytes from Peyer's patches, mesenteric lymph nodes, and spleen Journal of Immunology 136(1): 152-156
Crivellato, E.; Damiani, D.; Mallardi, F.; Travan, L. 1991: Suggestive evidence for a microanatomical relationship between mast cells and nerve fibres containing substance P, calcitonin gene related peptide, vasoactive intestinal polypeptide, and somatostatin in the rat mesentery Acta Anatomica 141(2): 127-131
Salam, F.Sarah.; Theodosiou, L.; Gillibrand, V.; Sharma, K. 2011: A retrospective audit of referrals of 16-17 year olds with reference to substance abuse Psychiatria Danubina 23 Suppl. 1: S194-S197